Activest Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
WT
AAS
WAM
RFM
NHFG
MFS
LRPA
WTC
SGH
Activest Wealth Management's XBI Position: Q2 2026 in Review
Activest Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.4% in Q2 2026, selling an estimated $4.06K and leaving 329 shares worth $52K. The position accounts for 0.01% of the portfolio, ranked #274.
Activest Wealth Management first reported a position in XBI in Q1 2021 and has held it in 17 quarters since. The position peaked at $153K in Q1 2021. 327 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Activest Wealth Management held 329 shares of State Street SPDR S&P Biotech ETF worth $52K as of Q2 2026.
- Activest Wealth Management sold 30 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $4.06K.
- State Street SPDR S&P Biotech ETF made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #274 holding.
- Activest Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 17 quarters since.
- Activest Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $153K in Q1 2021.
- 327 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.